Editorial: Advances in Plasma Cells in Health and Disease

Editorial: Advances in Plasma Cells in Health and Disease

Bibliographic Details
Main Authors:	F. Eun-Hyung Lee, Jens Wrammert, Simone Cenci
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Immunology
Subjects:	niche bone marrow allergy serological memory plasma cell multiple myeloma
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.606737/full

Similar Items

Advances in Plasma Cells in Health and Disease
Published: (2020)

Immunophenotype of normal and myelomatous plasma cell subsets
by: Nelly eRobillard, et al.
Published: (2014-03-01)

The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
by: Nikolaos Giannakoulas, et al.
Published: (2021-04-01)

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
by: Maaike V. J. Braham, et al.
Published: (2018-06-01)

Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells
by: Adam Utley, et al.
Published: (2020-07-01)

Autophagy in plasma cell pathophysiology
by: Laura eOliva, et al.
Published: (2014-03-01)

Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma
by: Kazuhito Suzuki, et al.
Published: (2021-01-01)

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
by: Almudena García-Ortiz, et al.
Published: (2021-01-01)

Game of Bones: How Myeloma Manipulates Its Microenvironment
by: Tyler Moser-Katz, et al.
Published: (2021-02-01)

Multiple myeloma presenting with coexisting severe marrow hypoplasia
by: Medhi K, et al.
Published: (2008-10-01)

Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory
by: Jean-Pascal Capp, et al.
Published: (2020-08-01)

Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event
by: Jean-Pascal Capp, et al.
Published: (2018-09-01)

Microfilaria of Wuchereria bancrofti in plasma cell myeloma: A case report
by: Sachin Kolte, et al.
Published: (2015-01-01)

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges
by: Vasileios Lazaris, et al.
Published: (2021-03-01)

Extramedullary Plasmacytoma Presenting as Lung Cancer
by: Gajanan S Gaude, et al.
Published: (2018-04-01)

Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
by: Jelena Bila, et al.
Published: (2021-08-01)

Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications
by: Jacqueline Schütt, et al.
Published: (2021-08-01)

Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia
by: Takanori Yamaguchi, et al.
Published: (2021-02-01)

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
by: Patricia Maiso, et al.
Published: (2021-05-01)

Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma
by: Anna Mansour, et al.
Published: (2017-08-01)

MORPHOLOGICAL FEATURES OF TUMORS SUBSTRATE IN MULTIPLE MYELOMA PATIENTS COMPLICATED WITH PLASMACYTOMA
by: M. V. Firsova, et al.
Published: (2018-07-01)

Etiological Profile of Plasmacytosis on Bone Marrow Aspirates
by: Monika Gupta, et al.
Published: (2016-03-01)

Metabolic Features of Multiple Myeloma
by: Chaima El Arfani, et al.
Published: (2018-04-01)

Boosting Immunity against Multiple Myeloma
by: Raquel Lopes, et al.
Published: (2021-03-01)

The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors
by: F. Gizem Sonugür, et al.
Published: (2019-10-01)

Quantification of plasma cell dynamics using mathematical modelling
by: Marcel Mohr, et al.
Published: (2018-01-01)

Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma
by: MV Firsova, et al.
Published: (2019-09-01)

NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma
by: Chia-Hung Yen, et al.
Published: (2018-11-01)

Evaluation of Correlation between Serum Free Light-Chain Assay and Bone Marrow Study in Multiple Myeloma Patients
by: Fatemeh Zamani, et al.
Published: (2021-07-01)

Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01)

Bone marrow blood vessels: normal and neoplastic niche
by: Saeid Shahrabi, et al.
Published: (2016-11-01)

Selective purging of human multiple myeloma cells from peripheral blood mononuclear cells: a preliminary study
by: Lee AJ, et al.
Published: (2019-04-01)

In the Right Place, at the Right Time: Spatiotemporal Conditions Determining Plasma Cell Survival and Function
by: Randall L. Lindquist, et al.
Published: (2019-04-01)

EXPRESSION OF GENES RESPONSIBLE FOR MULTIDRUG RESISTANCE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS
by: Yu. B. Chernykh, et al.
Published: (2016-02-01)

Bone Marrow Fat and Hematopoiesis
by: Huifang Wang, et al.
Published: (2018-11-01)

Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma
by: Shih-Feng Cho, et al.
Published: (2017-11-01)

Comparative Study of Quality of Life in Multiple Myeloma Patients after Bone Marrow Transplantation in Outpatient and Inpatient Setting
by: A Manookian, et al.
Published: (2010-06-01)

Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
by: Danielle Harmer, et al.
Published: (2019-01-01)

Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?
by: Edvan de Queiroz Crusoe, et al.

The Maintenance of Memory Plasma Cells
by: Laleh Khodadadi, et al.
Published: (2019-04-01)